Dassault Systèmes Acquires ArisGlobal in $1.8B Deal

Dassault Systèmes said it has agreed to acquire ArisGlobal for around $1.8 billion, plus some added payments that depend on hitting future AI revenue targets. In practice, the plan is to mash together ArisGlobal’s regulatory compliance and clinical data platform with Dassault Systèmes’ own strengths across drug discovery, clinical development, and manufacturing, so they can put together an AI-powered intelligence platform aimed at the life sciences business.

Also Read: Otsuka and Itabashi Ward Launch Community Health Program

ArisGlobal, for context, works with more than 200 organizations, including about half of the world’s top 50 biopharmaceutical companies and it also handles over 12 million patient safety reports every year. This purchase basically mirrors the industry’s bigger movement to align clinical information, regulatory insight and operational records all in one place, which should let healthcare organizations speed up research, tighten compliance, and back improved treatment outcomes via AI.